Histone Modification Therapy of Cancer
- 1 January 2010
- book chapter
- Published by Elsevier in Advances in Genetics
- Vol. 70, 341-386
- https://doi.org/10.1016/b978-0-12-380866-0.60013-7
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast CancerPublished by Elsevier ,2009
- Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive GenesPublished by Elsevier ,2009
- NA-Seq: A Discovery Tool for the Analysis of Chromatin Structure and Dynamics during DifferentiationDevelopmental Cell, 2009
- Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)Investigational New Drugs, 2008
- Epigenomic profiling of cancer cellsThe International Journal of Biochemistry & Cell Biology, 2008
- LSD1 and the chemistry of histone demethylationCurrent Opinion in Chemical Biology, 2007
- High-Resolution Profiling of Histone Methylations in the Human GenomePublished by Elsevier ,2007
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004
- Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate CancerThe Prostate, 2004